| Pamela Kuusisto, DO | |
|
16000 W Nine Mile Rd, Suite 601, Southfield, MI 48075 | |
| (586) 255-1603 | |
| Not Available |
| Full Name | Pamela Kuusisto |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 16000 W Nine Mile Rd, Southfield, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578792958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 5101018077 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford West Bloomfield Hospital | West bloomfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
| Henry Ford West Bloomfield Hospital | 2264589449 | 93 |
News Archive
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
Today's headlines include reports that the Obama administration is moving ahead in preparations for the health law's employer mandate.
A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.
In a host of neurological diseases, including multiple sclerosis (MS) and several neuropathies, the protective covering surrounding the nerves - an insulating material called myelin - is damaged.
› Verified 6 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003989690 PECOS PAC ID: 0547178311 Enrollment ID: O20031111000300 |
News Archive
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
Today's headlines include reports that the Obama administration is moving ahead in preparations for the health law's employer mandate.
A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.
In a host of neurological diseases, including multiple sclerosis (MS) and several neuropathies, the protective covering surrounding the nerves - an insulating material called myelin - is damaged.
› Verified 6 days ago
| Entity Name | Northland Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528001880 PECOS PAC ID: 5294623336 Enrollment ID: O20040309001092 |
News Archive
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
Today's headlines include reports that the Obama administration is moving ahead in preparations for the health law's employer mandate.
A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.
In a host of neurological diseases, including multiple sclerosis (MS) and several neuropathies, the protective covering surrounding the nerves - an insulating material called myelin - is damaged.
› Verified 6 days ago
| Entity Name | Providence Park Anesthesia Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942459672 PECOS PAC ID: 7315009479 Enrollment ID: O20081224000115 |
News Archive
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
Today's headlines include reports that the Obama administration is moving ahead in preparations for the health law's employer mandate.
A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.
In a host of neurological diseases, including multiple sclerosis (MS) and several neuropathies, the protective covering surrounding the nerves - an insulating material called myelin - is damaged.
› Verified 6 days ago
| Entity Name | Henry Ford West Bloomfield Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518104686 PECOS PAC ID: 2264589449 Enrollment ID: O20090403000176 |
News Archive
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
Today's headlines include reports that the Obama administration is moving ahead in preparations for the health law's employer mandate.
A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.
In a host of neurological diseases, including multiple sclerosis (MS) and several neuropathies, the protective covering surrounding the nerves - an insulating material called myelin - is damaged.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pamela Kuusisto, DO 16000 W 9 Mile Rd, Suite 601, Southfield, MI 48075-4808 Ph: (586) 255-1603 | Pamela Kuusisto, DO 16000 W Nine Mile Rd, Suite 601, Southfield, MI 48075 Ph: (586) 255-1603 |
News Archive
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
Today's headlines include reports that the Obama administration is moving ahead in preparations for the health law's employer mandate.
A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.
In a host of neurological diseases, including multiple sclerosis (MS) and several neuropathies, the protective covering surrounding the nerves - an insulating material called myelin - is damaged.
› Verified 6 days ago
Jonathan Arie Kroll, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Dominick Lago Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Jeffrey Joseph Kirouac, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Leslie A Mumaw, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26051 Lahser Rd, Southfield, MI 48034 Phone: 248-223-9945 | |
Mark Mounayer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26025 Lahser Rd Fl 3, Southfield, MI 48033 Phone: 248-663-1900 Fax: 248-663-1901 | |
Dr. Alexander Grossi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16000 W 9 Mile Rd, Suite 601, Southfield, MI 48075 Phone: 734-233-8481 | |
Shad Siddiqi, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22250 Providence Dr Ste 401, Southfield, MI 48075 Phone: 866-974-2673 Fax: 866-939-2673 |